Par Drugs and Chemicals Ltd
NSE:PAR
Cash Flow Statement
Cash Flow Statement
Par Drugs and Chemicals Ltd
| Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Net Income |
151
|
169
|
195
|
246
|
179
|
|
| Depreciation & Amortization |
32
|
33
|
34
|
35
|
36
|
|
| Other Non-Cash Items |
(2)
|
(1)
|
(3)
|
(4)
|
(11)
|
|
| Cash Taxes Paid |
43
|
44
|
44
|
50
|
45
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(47)
|
27
|
(24)
|
(105)
|
(43)
|
|
| Cash from Operating Activities |
134
N/A
|
227
+70%
|
202
-11%
|
172
-15%
|
162
-6%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(76)
|
(87)
|
(61)
|
(28)
|
(12)
|
|
| Other Items |
3
|
1
|
2
|
(256)
|
(240)
|
|
| Cash from Investing Activities |
(73)
N/A
|
(86)
-17%
|
(58)
+32%
|
(283)
-385%
|
(252)
+11%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
(36)
|
0
|
0
|
0
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
|
| Other |
(0)
|
(0)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
(0)
N/A
|
(36)
-150 679%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Change in Cash | ||||||
| Net Change in Cash |
60
N/A
|
105
+74%
|
144
+37%
|
(111)
N/A
|
(90)
+19%
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
57
N/A
|
141
+145%
|
142
+1%
|
144
+2%
|
150
+4%
|
|